Share chart Arcus Biosciences, Inc.
Extended chart
Simple chart
About Arcus Biosciences, Inc.
Arcus Biosciences, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается разработкой и коммерциализацией методов лечения рака в Соединенных Штатах. Ассортимент продукции компании включает AB928, двойной антагонист аденозиновых рецепторов A2aA2b, который проходит фазу 1b2 клинических испытаний; и Зимберелимаб, моноклональное антитело против PD-1, которое проходит фазу Ib клинических испытаний для монотерапии. more detailsIPO date | 2018-03-15 |
---|---|
ISIN | US03969F1093 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.arcusbio.com |
Цена ао | 8.4 |
Change price per day: | -1.31% (8.41) |
---|---|
Change price per week: | +5.33% (7.88) |
Change price per month: | +0.4843% (8.26) |
Change price per 3 month: | -36.93% (13.16) |
Change price per half year: | -50.18% (16.66) |
Change price per year: | -43.65% (14.73) |
Change price per 3 year: | -61.31% (21.45) |
Change price per 5 year: | -72.41% (30.08) |
Change price per year to date: | -47.83% (15.91) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Blackrock Inc. | 10035170 | 11.04 |
FMR, LLC | 4728782 | 5.2 |
Vanguard Group Inc | 4680716 | 5.15 |
State Street Corporation | 4239577 | 4.67 |
Octagon Capital Advisors LP | 1868000 | 2.06 |
Ameriprise Financial, Inc. | 1634805 | 1.8 |
Invus Financial Advisors, LLC | 1612077 | 1.77 |
Boxer Capital, LLC | 1602200 | 1.76 |
Dimensional Fund Advisors LP | 1594609 | 1.75 |
AllianceBernstein L.P. | 1185944 | 1.31 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Syntax Stratified SmallCap ETF | 0.14556 | 13.51 | 1.639 |
iShares Morningstar Small-Cap Growth ETF | 0.02041 | 596.94 | 0.72598 |
iShares Morningstar Small-Cap ETF | 0.01843 | 391.25 | 1.60498 |
iShares Morningstar Small-Cap Value ETF | 0.01642 | 197.28 | 2.50476 |
0.05 | 299.75 | 1.62 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Terry J. Rosen Ph.D. | Co-Founder, Chairman & CEO | 756.11k | 1960 (65 years) |
Mr. Robert C. Goeltz II | Principal Financial Officer & CFO | 745.29k | 1973 (52 years) |
Dr. Juan Carlos Jaen Ph.D. | Co- Founder & President | 931.14k | 1958 (67 years) |
Dr. Jonathan Yingling Ph.D. | Chief Scientific Officer | N/A | 1969 (56 years) |
Ms. Jennifer A. Jarrett M.B.A. | Chief Operating Officer | 925.29k | 1971 (54 years) |
Mr. Alexander Azoy | VP of Finance & Principal Accounting Officer | N/A | 1976 (49 years) |
Dr. Dimitry S.A. Nuyten M.D., Ph.D. | Chief Medical Officer | 700.34k | 1976 (49 years) |
Dr. K. Christopher Garcia Ph.D. | Co-Founder & Member of Scientific Advisory Board | N/A | |
Ms. Carolyn C. Tang J.D. | General Counsel & Corporate Secretary | 1979 (46 years) | |
Holli Kolkey | Vice President of Corporate Communications |
Address: United States, Hayward, 3928 Point Eden Way - open in Google maps, open in Yandex maps
Website: http://www.arcusbio.com
Website: http://www.arcusbio.com